$TRNS
TRANSCAT INC Stock $trns

$trns Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924025176 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$67.83M	$66.71M
YoY Change	8.0%	10.08%
Cost Of Revenue	$46.62M	$44.05M
YoY Change	9.23%	5.17%
Gross Profit	$21.21M	$22.66M
YoY Change	5.37%	21.08%
Gross Profit Margin	31.27%	33.96%
Selling, General & Admin	$17.47M	$17.56M
YoY Change	-5.47%	26.44%
% of Gross Profit	82.39%	77.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.400M	$4.113M
YoY Change	33.74%	47.42%
% of Gross Profit	20.75%	18.15%
Operating Expenses	$17.47M	$17.56M
YoY Change	-5.47%	26.44%
Operating Profit	$3.735M	$5.099M
YoY Change	127.33%	5.68%
Interest Expense	$210.0K	$260.0K
YoY Change	-123.6%	-131.94%
% of Operating Profit	5.62%	5.1%
Other Income/Expense, Net	-$232.0K	-$131.0K
YoY Change	-72.41%	104.69%
Pretax Income	$3.713M	$5.228M
YoY Change	362.97%	38.97%
Income Tax	$427.0K	$820.0K
% Of Pretax Income	11.5%	15.68%
Net Earnings	$3.286M	$4.408M
YoY Change	614.35%	49.47%
Net Earnings / Revenue	4.84%	6.61%
Basic Earnings Per Share	$0.36	$0.49
Diluted Earnings Per Share	$0.35	$0.48
COMMON SHARES
Basic Shares Outstanding	9.145M	9.134M
Diluted Shares Outstanding	9.282M	9.196M

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.82M	$22.66M
YoY Change	1884.58%	954.3%
Cash & Equivalents	$23.82M	$22.66M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$6.241M	$5.070M
YoY Change	78.31%	49.43%
Inventory	$15.55M	$18.13M
Prepaid Expenses
Receivables	$48.93M	$48.16M
Other Receivables	$628.0K	$242.0K
Total Short-Term Assets	$95.17M	$94.25M
YoY Change	46.02%	48.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$64.80M	$63.95M
YoY Change	81.78%	37.63%
Goodwill	$138.1M	$138.1M
YoY Change	29.86%	79.29%
Intangibles	$24.36M	$26.25M
YoY Change	5.21%	73.36%
Long-Term Investments
YoY Change
Other Assets	$1.096M	$1.049M
YoY Change	1.2%	-1.59%
Total Long-Term Assets	$228.4M	$229.4M
YoY Change	24.78%	64.18%
TOTAL ASSETS
Total Short-Term Assets	$95.17M	$94.25M
Total Long-Term Assets	$228.4M	$229.4M
Total Assets	$323.6M	$323.7M
YoY Change	30.35%	59.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.04M	$13.08M
YoY Change	4.15%	13.08%
Accrued Expenses	$11.09M	$12.68M
YoY Change	-3.55%	36.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.386M	$2.362M
YoY Change	4.06%	4.05%
Total Short-Term Liabilities	$26.52M	$31.80M
YoY Change	-5.66%	34.04%
LONG-TERM LIABILITIES
Long-Term Debt	$612.0K	$1.218M
YoY Change	-98.8%	-97.36%
Other Long-Term Liabilities	$18.37M	$19.06M
YoY Change	235.33%	22.08%
Total Long-Term Liabilities	$18.98M	$20.28M
YoY Change	-66.4%	-67.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.52M	$31.80M
Total Long-Term Liabilities	$18.98M	$20.28M
Total Liabilities	$54.80M	$61.36M
YoY Change	-50.17%	-33.74%
SHAREHOLDERS EQUITY
Retained Earnings	$85.89M	$83.52M
YoY Change	20.94%	16.16%
Common Stock	$183.6M	$179.9M
YoY Change	168.8%	354.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$268.8M	$262.3M
YoY Change
Total Liabilities & Shareholders Equity	$323.6M	$323.7M
YoY Change	30.35%	59.18%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$3.286M	$4.408M
YoY Change	614.35%	49.47%
Depreciation, Depletion And Amortization	$4.400M	$4.113M
YoY Change	33.74%	47.42%
Cash From Operating Activities	$6.835M	$8.924M
YoY Change	-18.92%	18.42%
INVESTING ACTIVITIES
Capital Expenditures	$3.959M	$3.674M
YoY Change	48.28%	32.78%
Acquisitions		$15.95M
YoY Change		456.05%
Other Investing Activities	$95.00K	-$420.0K
YoY Change	-100.95%	-85.36%
Cash From Investing Activities	-$3.864M	-$4.094M
YoY Change	-69.55%	-27.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$576.0K
YoY Change		4.16%
Cash From Financing Activities	-1.411M	-1.935M
YoY Change	-144.51%	125.26%
NET CHANGE
Cash From Operating Activities	6.835M	8.924M
Cash From Investing Activities	-3.864M	-4.094M
Cash From Financing Activities	-1.411M	-1.935M
Net Change In Cash	1.560M	2.895M
YoY Change	-243.12%	178.1%
FREE CASH FLOW
Cash From Operating Activities	$6.835M	$8.924M
Capital Expenditures	$3.959M	$3.674M
Free Cash Flow	$2.876M	$5.250M
YoY Change	-50.07%	10.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-30
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	492000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	544000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.5
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.5
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9144731
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9144731
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8839299
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8839299
CY2023Q1	us-gaap	Investments Investments	100000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2023Q2	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	0.01
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-06-29
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity File Number EntityFileNumber	000-03905
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-0874418
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	35 Vantage Point Drive
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Rochester
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14624
CY2024Q2	dei	City Area Code CityAreaCode	585
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	352-7777
CY2024Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.50 par value
CY2024Q2	dei	Trading Symbol TradingSymbol	TRNS
CY2024Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9145144
CY2024Q2	us-gaap	Revenues Revenues	66707000	usd
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44052000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	41888000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	22655000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	18710000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7801000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6469000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9755000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7601000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	17556000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	14070000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5099000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4640000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	52000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	814000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	312000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	-0	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-131000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-64000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	129000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-878000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5228000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3762000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	820000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	813000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	4408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9064000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7622000
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9196000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7762000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	4408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-161000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	476000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-155000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	482000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4253000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3431000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22657000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19646000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15533000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48156000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47779000	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	242000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	506000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	18128000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	17418000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5070000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4276000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	94253000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	105158000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45954000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38944000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	138146000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	105585000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26254000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19987000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17996000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16823000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1049000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1055000	usd
CY2024Q2	us-gaap	Assets Assets	323652000	usd
CY2024Q1	us-gaap	Assets Assets	287552000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13076000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11495000	usd
CY2024Q2	trns	Accrued Compensation And Other Liabilities Current AccruedCompensationAndOtherLiabilitiesCurrent	12677000	usd
CY2024Q1	trns	Accrued Compensation And Other Liabilities Current AccruedCompensationAndOtherLiabilitiesCurrent	16739000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3687000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2926000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2362000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2339000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	31802000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33499000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1218000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1817000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9287000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9291000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15400000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14873000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3657000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2903000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	61364000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	62383000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	4572000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4420000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	175299000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	141624000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1104000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-949000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	83521000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	80074000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	262288000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	225169000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	323652000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	287552000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	4408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
CY2024Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4000	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	44000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4113000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2790000	usd
CY2024Q2	trns	Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown	-89000	usd
CY2023Q2	trns	Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown	138000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	697000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	930000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-2814000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-3115000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	235000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1950000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	687000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-531000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1425000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4315000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4273000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1203000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	759000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	599000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8924000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7536000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3674000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2767000	usd
CY2024Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15953000	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2869000	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15533000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4094000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5636000	usd
CY2024Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-204000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	576000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	553000	usd
CY2024Q2	trns	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	260000	usd
CY2023Q2	trns	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	199000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1619000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	301000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1935000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-859000	usd
CY2024Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	116000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-423000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3011000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	618000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19646000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1531000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22657000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2149000	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	259000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	816000	usd
CY2024Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	63000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	107000	usd
CY2024Q2	us-gaap	Stock Issued1 StockIssued1	32781000	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	6831000	usd
CY2024Q2	trns	Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition	1250000	usd
CY2023Q2	trns	Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition	0	usd
CY2024Q2	trns	Noncash Or Part Noncash Acquisition Contingent Consideration Treated As Equity NoncashOrPartNoncashAcquisitionContingentConsiderationTreatedAsEquity	750000	usd
CY2023Q2	trns	Noncash Or Part Noncash Acquisition Contingent Consideration Treated As Equity NoncashOrPartNoncashAcquisitionContingentConsiderationTreatedAsEquity	0	usd
CY2024Q2	trns	Reclassification Of Property And Equipment To Inventory ReclassificationOfPropertyAndEquipmentToInventory	410000	usd
CY2023Q2	trns	Reclassification Of Property And Equipment To Inventory ReclassificationOfPropertyAndEquipmentToInventory	230000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	99630000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7030000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	301000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	930000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	482000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	110720000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	225169000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33039000	usd
CY2024Q2	trns	Adjustments To Additional Paid In Capital Contingent Consideration AdjustmentsToAdditionalPaidInCapitalContingentConsideration	750000	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1620000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	697000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-155000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	4408000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	262288000	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates: </b>The preparation of Transcat’s Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States ("GAAP") requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but <em style="font: inherit;">not</em> limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements <em style="font: inherit;"> may </em>change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;"></p>
CY2024Q2	trns	Revenue Recognition Percentage Of Net Sales RevenueRecognitionPercentageOfNetSales	1	pure
CY2023Q2	trns	Revenue Recognition Percentage Of Net Sales RevenueRecognitionPercentageOfNetSales	1	pure
CY2024Q2	us-gaap	Investments Investments	100000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.5
CY2024Q2	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	0.01
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9064000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7622000
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	132000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	140000
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9196000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7762000
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35000
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57000
CY2024Q1	us-gaap	Goodwill Goodwill	105585000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19987000	usd
CY2024Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	32622000	usd
CY2024Q2	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	8040000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	-0	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1773000	usd
CY2024Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-61000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	0	usd
CY2024Q2	us-gaap	Goodwill Goodwill	138146000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26254000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4074000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5508000	usd
CY2024Q2	trns	Accrued Incentive Current AccruedIncentiveCurrent	986000	usd
CY2024Q1	trns	Accrued Incentive Current AccruedIncentiveCurrent	4182000	usd
CY2024Q2	trns	Current Portion Of Lease Liabilities CurrentPortionOfLeaseLiabilities	3177000	usd
CY2024Q1	trns	Current Portion Of Lease Liabilities CurrentPortionOfLeaseLiabilities	2510000	usd
CY2024Q2	trns	Accrued Acquisition Holdbacks Current AccruedAcquisitionHoldbacksCurrent	3216000	usd
CY2024Q1	trns	Accrued Acquisition Holdbacks Current AccruedAcquisitionHoldbacksCurrent	2577000	usd
CY2024Q2	trns	Accrued Sales Tax Current AccruedSalesTaxCurrent	727000	usd
CY2024Q1	trns	Accrued Sales Tax Current AccruedSalesTaxCurrent	813000	usd
CY2024Q2	trns	Accrued Contingent Consideration AccruedContingentConsideration	0	usd
CY2024Q1	trns	Accrued Contingent Consideration AccruedContingentConsideration	529000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	497000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	620000	usd
CY2024Q2	trns	Accrued Compensation And Other Current Liabilities AccruedCompensationAndOtherCurrentLiabilities	12677000	usd
CY2024Q1	trns	Accrued Compensation And Other Current Liabilities AccruedCompensationAndOtherCurrentLiabilities	16739000	usd
CY2024Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1130000	usd
CY2024Q1	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1134000	usd
CY2024Q2	trns	Accrued Acquisition Holdbacks Noncurrent AccruedAcquisitionHoldbacksNoncurrent	1647000	usd
CY2024Q1	trns	Accrued Acquisition Holdbacks Noncurrent AccruedAcquisitionHoldbacksNoncurrent	1647000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	750000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2024Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	130000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	122000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3657000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2903000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	600000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	100000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	234000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.43
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	108.04
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	24.3
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12000
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.64
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	222000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.91
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	12159000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	63000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	36.21
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	4750000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2024Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2024Q2	us-gaap	Revenues Revenues	66707000	usd
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	22655000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	18710000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	17556000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	14070000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5099000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4640000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	129000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-878000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	820000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	813000	usd
CY2024Q2	us-gaap	Other General Expense OtherGeneralExpense	691000	usd
CY2023Q2	us-gaap	Other General Expense OtherGeneralExpense	1691000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	4408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2024Q2	us-gaap	Revenues Revenues	66707000	usd
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	66727000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	68374000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	4420000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3790000	usd
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.49
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.5
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.48
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.49
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3200000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	800000	usd
CY2024Q2	trns	Unpaid Amounts For Other Holdbacks UnpaidAmountsForOtherHoldbacks	1600000	usd
CY2023Q2	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023Q2	trns	Payments For Other Holdbacks PaymentsForOtherHoldbacks	300000	usd
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	400000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	200000	usd

Files In Submission

Name	View Source	Status
0001437749-24-025176-index-headers.html	Edgar Link	pending
0001437749-24-025176-index.html	Edgar Link	pending
0001437749-24-025176.txt	Edgar Link	pending
0001437749-24-025176-xbrl.zip	Edgar Link	pending
ex_686941.htm	Edgar Link	pending
ex_686942.htm	Edgar Link	pending
ex_686943.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trns-20240629.xsd	Edgar Link	pending
trns-20240629_cal.xml	Edgar Link	unprocessable
trns20240611_10q.htm	Edgar Link	pending
trns-20240629_lab.xml	Edgar Link	unprocessable
trns-20240629_pre.xml	Edgar Link	unprocessable
trns20240611_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
trns-20240629_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNS
TRANSCAT INC Stock $trns

2024 Q3 Form 10-Q Financial Statement

#000143774924025176 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS TRANSCAT INC Stock $trns

2024 Q3 Form 10-Q Financial Statement

#000143774924025176 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS
TRANSCAT INC Stock $trns